ARYA Sciences Acquisition... (ARYD)
NASDAQ: ARYD
· Real-Time Price · USD
6.64
-2.46 (-27.03%)
At close: Jul 31, 2024, 10:00 PM
ARYA Sciences Acquisition Corp IV Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 87.5K | 20.19K | 13.81K | 18.03K | 60.02K | 91.05K | 23.13K | 49.53K | 379.38K | 501.24K | 623.64K | 757.25K | 810.09K |
Short-Term Investments | n/a | 40.58M | 39.63M | 38.71M | 38.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 37.12M | 40.58M | 39.63M | 38.71M | 38.11M | 151.63M | 150.45M | 149.7M | 149.59M | 149.55M | 149.53M | 149.52M | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 149.52M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 53.4K | 56.55K | 157.62K | 264K | 54.15K | 55.4K | 150.9K | 246.4K | 341.9K | 368.8K | 450.99K | 534.67K | 620.21K |
Total Current Assets | 140.9K | 76.74K | 171.43K | 282.04K | 114.17K | 146.45K | 174.03K | 295.94K | 721.28K | 870.04K | 1.07M | 1.29M | 1.43M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 37.12M | 40.58M | 39.63M | 38.71M | 38.11M | 151.63M | 150.45M | 149.7M | 149.59M | 149.55M | 149.53M | 149.52M | 149.52M |
Total Assets | 37.26M | 40.65M | 39.8M | 38.99M | 38.22M | 151.78M | 150.62M | 150M | 150.32M | 150.42M | 150.61M | 150.81M | 150.95M |
Account Payables | 157.78K | 130.52K | 89.31K | 79.61K | 68.81K | 65.89K | 67.07K | 67.07K | 228.95K | 173.07K | 9.15K | 6.5K | 550.00 |
Deferred Revenue | -157.78K | -130.52K | -1.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 3.15M | 2.17M | 1.71M | 1.26M | 720K | 120K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.84M | 10.05M | 7.49M | 6.67M | 6.84M | 6.08M | 5.96M | 5.9M | 5.86M | 5.81M | 5.06M | 178.85K | 156.27K |
Total Current Liabilities | 12.15M | 12.35M | 9.28M | 8.01M | 7.63M | 6.27M | 6.03M | 5.97M | 6.09M | 5.99M | 5.07M | 185.35K | 156.82K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.62M | 2.62M | 2.62M | 2.62M | 2.62M | n/a | 2.62M | 5.23M | 5.23M | 5.23M | 5.23M | 5.23M | n/a |
Total Long-Term Liabilities | 2.62M | 2.62M | 2.62M | 2.62M | 2.62M | 2.62M | 2.62M | 5.23M | 5.23M | 5.23M | 5.23M | 5.23M | 5.23M |
Total Liabilities | 14.76M | 14.97M | 11.9M | 10.63M | 10.24M | 8.89M | 8.64M | 11.2M | 11.32M | 11.22M | 10.31M | 5.42M | 5.39M |
Total Debt | 3.15M | 2.17M | 1.71M | 1.26M | 720K | 120K | 60K | 30K | 30K | n/a | n/a | n/a | 11.07K |
Common Stock | 37.02M | 40.48M | 39.53M | 38.61M | 38.01M | 151.53M | 150.35M | 149.6M | 149.5M | 149.5M | 149.5M | 140.39M | 140.56M |
Retained Earnings | -15.04M | -14.79M | -11.63M | -10.25M | -10.03M | -8.64M | -8.37M | -10.81M | -10.51M | -10.3M | -9.2M | -386.22K | -223.79K |
Comprehensive Income | -0.00 | n/a | n/a | -0.00 | -0.00 | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 22.5M | 25.68M | 27.9M | 28.36M | 27.98M | 142.89M | 141.98M | 138.8M | 138.99M | 139.2M | 140.3M | 145.39M | 145.56M |
Total Investments | 37.12M | 40.58M | 39.63M | 38.71M | 38.11M | 151.63M | 150.45M | 149.7M | 149.59M | 149.55M | 149.53M | 149.52M | n/a |